All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a healthcare professional. If you are a patient or carer, please visit Know GvHD.
The GvHD Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the GvHD Hub cannot guarantee the accuracy of translated content. The GvHD Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
The GvHD Hub is an independent medical education platform, sponsored by Medac and supported through grants from Sanofi and Therakos. Funders are allowed no direct influence on our content. The levels of sponsorship listed are reflective of the amount of funding given. View funders.
Now you can support HCPs in making informed decisions for their patients
Your contribution helps us continuously deliver expertly curated content to HCPs worldwide. You will also have the opportunity to make a content suggestion for consideration and receive updates on the impact contributions are making to our content.
Find out more
Create an account and access these new features:
Bookmark content to read later
Select your specific areas of interest
View GvHD content recommended for you
On March 24, 2026, the GvHD Hub held a live symposium at the 52nd Annual Meeting of the EBMT, titled “Focusing GvHD care through the eyes of providers and patients: Practical insights on ECP”. The symposium was chaired by Hildegard Greinix, with presentations from Michelle Kenyon and Matea Meden, and included an opportunity for the audience to ask questions. Explore each session from the symposium below:
Michelle Kenyon, King’s College Hospital NHS Foundation Trust, London, UK, presented the first session, titled “The role of nurses within the multidisciplinary GvHD care team” at the recent GvHD Hub live symposium.
Hildegard Greinix, Medical University of Vienna, Vienna, AT, presented the second session, titled “Physician’s perspective: How I treat GvHD with ECP” at the recent GvHD Hub live symposium.
Matea Meden, Sisan, HR, presented the third session, titled “Patient’s perspective: My journey with GvHD” at the recent GvHD Hub live symposium.
This educational activity is independently supported by Therakos. All content was developed by the faculty in collaboration with SES. Funders were allowed no influence.
Please indicate your level of agreement with the following statements:
The content was clear and easy to understand
The content addressed the learning objectives
The content was relevant to my practice
I will change my clinical practice as a result of this content
More from this series:
Your opinion matters
What do you consider to be the main potential advantage of mesenchymal stromal cells in the treatment of acute GvHD?
Hildegard Greinix
Matea Meden
Michelle Kenyon
